| abstract |
The present invention relates to novel host cell targets for antiviral, preferably anti-hepatitisnC virus (HCV), compounds identified by analysis of HCV replicon-regulatednpolypeptide expression, to prognostic markers for the prediction of the outcome of anviral infection, to in vitro methods for the prediction of the outcome of a HCV infectionnin a subject, to screening methods for identifying compounds which interact with and/ornmodulate the activity of the novel host cell targets or which modulate the expression ofnsaid novel host cell targets. |